Related references
Note: Only part of the references are listed.Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease
Qiang Zhang et al.
EUROPEAN UROLOGY (2018)
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-β signaling
Linjia Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates
Tianxia Guan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
Christopher C. Kloss et al.
MOLECULAR THERAPY (2018)
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello et al.
NATURE (2018)
Contextual determinants of TGFβ action in development, immunity and cancer
Charles J. David et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
TH9 cells in anti-tumor immunity
Thaiz Rivera Vargas et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells
Tom L. Stephen et al.
IMMUNITY (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis
Ying Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
Isabelle Riviere et al.
MOLECULAR THERAPY (2017)
Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation
Song Zhang et al.
NATURE (2017)
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment
Michael W. Pickup et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
Shomyseh Sanjabi et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Induction of resident memory T cells enhances the efficacy of cancer vaccine
Mevyn Nizard et al.
NATURE COMMUNICATIONS (2017)
Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
Masaki Terabe et al.
ONCOIMMUNOLOGY (2017)
TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma
Brian Hutzen et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao et al.
NATURE IMMUNOLOGY (2017)
TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis
Daniel R. Principe et al.
CANCER RESEARCH (2016)
Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells
Saida Dadi et al.
CELL (2016)
Autocrine TGF-β/ZEB/microRNA-200 signal transduction drives epithelial-mesenchymal transition: Kinetic models predict minimal drug dose to inhibit metastasis
Katja Rateitschak et al.
CELLULAR SIGNALLING (2016)
CD103 and Intratumoral Immune Response in Breast Cancer
Zhi-Qiang Wang et al.
CLINICAL CANCER RESEARCH (2016)
Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands
Victor S. Cortez et al.
IMMUNITY (2016)
TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections
Gavin M. Lewis et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
ZEB1 drives epithelial-to-mesenchymal transition in lung cancer
Jill E. Larsen et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
Yinghua Zhao et al.
NATURE COMMUNICATIONS (2016)
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Benjamin V. Park et al.
CANCER DISCOVERY (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients
Yumi Nonomura et al.
ONCOIMMUNOLOGY (2016)
TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies
Tristan Courau et al.
JCI INSIGHT (2016)
TGF-β signaling in the control of hematopoietic stem cells
Ulrika Blank et al.
BLOOD (2015)
TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
Claire Vanpouille-Box et al.
CANCER RESEARCH (2015)
Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg17) cells in type 1 diabetes in non-obese diabetic mice
S. M. Bellemore et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation
John J. Worthington et al.
IMMUNITY (2015)
T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
Laura K. Mackay et al.
IMMUNITY (2015)
Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation
Maruf Hasan et al.
IMMUNOLOGY AND CELL BIOLOGY (2015)
CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
Faycal Djenidi et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL
Yujiang Fang et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Alexandre Calon et al.
NATURE GENETICS (2015)
Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells
Il-Kyu Kim et al.
NATURE MEDICINE (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Transforming growth factor-β signaling is constantly shaping memory T-cell population
Chaoyu Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
Xiang Xiao et al.
NATURE COMMUNICATIONS (2015)
PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
John R. Webb et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
Zhenghong Xu et al.
ACS NANO (2014)
TGF-beta Activation and Function in Immunity
Mark A. Travis et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Chimeric Antigen Receptor Therapy for Cancer
David M. Barrett et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer
John R. Webb et al.
CLINICAL CANCER RESEARCH (2014)
T lymphocytes targeting native receptors
Cliona M. Rooney et al.
IMMUNOLOGICAL REVIEWS (2014)
Targeting miR-23a in CD8(+) cytotoxic T lymphocytes prevents tumor-dependent immunosuppression
Regina Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Release of Active TGF-β1 from the Latent TGF-β1/GARP Complex on T Regulatory Cells Is Mediated by Integrin β8
Justin P. Edwards et al.
JOURNAL OF IMMUNOLOGY (2014)
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours
Jerome Galon et al.
JOURNAL OF PATHOLOGY (2014)
Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers
Yong Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TGF-β signaling to chromatin: How Smads regulate transcription during self-renewal and differentiation
Tessa Gaarenstroom et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Th17 cellsin cancer: the ultimate identity crisis
Stefanie R. Bailey et al.
FRONTIERS IN IMMUNOLOGY (2014)
Enhanced Effector Responses in Activated CD8+ T Cells Deficient in Diacylglycerol Kinases
Matthew J. Riese et al.
CANCER RESEARCH (2013)
Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
Jeong-Hwan Yoon et al.
EMBO MOLECULAR MEDICINE (2013)
The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells
J-S Delisle et al.
GENES AND IMMUNITY (2013)
Truncated Form of TGF-βRII, But Not Its Absence, Induces Memory CD8+ T Cell Expansion and Lymphoproliferative Disorder in Mice
Harumichi Ishigame et al.
JOURNAL OF IMMUNOLOGY (2013)
Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells
Cara N. Skon et al.
NATURE IMMUNOLOGY (2013)
The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
Laura K. Mackay et al.
NATURE IMMUNOLOGY (2013)
Selection of Self-Reactive T Cells in the Thymus
Gretta L. Stritesky et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Roles of Transforming Growth Factor-β in Graft-versus-Host and Graft-versus-Tumor Effects
Cedric Carli et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Alexandre Calon et al.
CANCER CELL (2012)
The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis
Kendra Garrison et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
Fanny Chalmin et al.
IMMUNITY (2012)
Transforming Growth Factor-β Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4+ and CD8+ T Cells
Ved Prakash Dwivedi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Th9 cells promote antitumor immune responses in vivo
Yong Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Cell-Intrinsic Abrogation of TGF-β Signaling Delays but Does Not Prevent Dysfunction of Self/Tumor-Specific CD8 T Cells in a Murine Model of Autochthonous Prostate Cancer
Cassie K. Chou et al.
JOURNAL OF IMMUNOLOGY (2012)
B Lymphocyte-Induced Maturation Protein-1 Contributes to Intestinal Mucosa Homeostasis by Limiting the Number of IL-17-Producing CD4+ T Cells
Soofia Salehi et al.
JOURNAL OF IMMUNOLOGY (2012)
Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties
Sergey V. Novitskiy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
TGF-β signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation
Nu Zhang et al.
NATURE IMMUNOLOGY (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park et al.
NATURE MATERIALS (2012)
Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
Steven A. Rosenberg
SCIENCE TRANSLATIONAL MEDICINE (2012)
Molecular mechanisms of Treg-mediated T cell suppression
Angelika Schmidt et al.
FRONTIERS IN IMMUNOLOGY (2012)
Tgf-β1 produced by activated CD4+ T Cells Antagonizes T Cell Surveillance of Tumor Development
Moses K. Donkor et al.
ONCOIMMUNOLOGY (2012)
SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage
Martin Giroux et al.
BLOOD (2011)
Transforming growth factor-β and the hallmarks of cancer
Maozhen Tian et al.
CELLULAR SIGNALLING (2011)
Intestinal Dendritic Cells Specialize to Activate Transforming Growth Factor-β and Induce Foxp3+ Regulatory T Cells via Integrin αvβ8
John J. Worthington et al.
GASTROENTEROLOGY (2011)
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
Moses K. Donkor et al.
IMMUNITY (2011)
Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice
Jennifer Nancy Hahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cancer Immunotherapy Comes of Age
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Generation of Human Regulatory γδ T Cells by TCRγδ Stimulation in the Presence of TGF-β and Their Involvement in the Pathogenesis of Systemic Lupus Erythematosus
Xiaoyan Li et al.
JOURNAL OF IMMUNOLOGY (2011)
An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
Philip A. Gregory et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion Role of EMT promoting Smad complexes
Jonas Fuxe et al.
CELL CYCLE (2010)
Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor beta-Insensitive CD8(+) T Cells
Longxin Wang et al.
CLINICAL CANCER RESEARCH (2010)
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development
Weiming Ouyang et al.
IMMUNITY (2010)
Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells
Shun Takaku et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice
Andrew C. Melton et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
T Cell Activation Leads to Protein Kinase Cθ-Dependent Inhibition of TGF-β Signaling
Martin Giroux et al.
JOURNAL OF IMMUNOLOGY (2010)
T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
Yibei Zhu et al.
JOURNAL OF IMMUNOLOGY (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
Ryo Ueda et al.
CLINICAL CANCER RESEARCH (2009)
Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor-β Monoclonal Antibody
Masaki Terabe et al.
CLINICAL CANCER RESEARCH (2009)
Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg
Julie Stockis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Transforming growth factor-beta signaling and tumor angiogenesis
Evangelia Pardali et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Mechanisms of the epithelial-mesenchymal transition by TGF-beta
Michael K. Wendt et al.
FUTURE ONCOLOGY (2009)
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue
N. Chaput et al.
GUT (2009)
Transcriptional Repressor Blimp-1 Promotes CD8+ T Cell Terminal Differentiation and Represses the Acquisition of Central Memory T Cell Properties
Rachel L. Rutishauser et al.
IMMUNITY (2009)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells
Shomyseh Sanjabi et al.
IMMUNITY (2009)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses
Axel Kallies et al.
IMMUNITY (2009)
Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation
Jyoti Das et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Down-regulation of Gfi-1 expression by TGF-β is important for differentiation of Th17 and CD103+ inducible regulatory T cells
Jinfang Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
Fernando Cruz-Guilloty et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cutting Edge: TGF-β1 and IL-15 Induce FOXP3+ γδ Regulatory T Cells in the Presence of Antigen Stimulation
Rita Casetti et al.
JOURNAL OF IMMUNOLOGY (2009)
GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells
Dat Q. Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Expression of GARP selectively identifies activated human FOXP3+regulatory T cells
Rui Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Transforming growth factor-β suppresses the activation of CD8+ T-Cells when naive but promotes their survival and function once antigen experienced -: a two-faced once antigen autoimmunity
Christophe M. Filippi et al.
DIABETES (2008)
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs
Xuexian O. Yang et al.
IMMUNITY (2008)
TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and antibody-dependent cellular cytotoxicity in human NK cells
Rossana Trotta et al.
JOURNAL OF IMMUNOLOGY (2008)
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-β receptor
Aaron E. Foster et al.
JOURNAL OF IMMUNOTHERAPY (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells
Yongzhong Liu et al.
NATURE IMMUNOLOGY (2008)
Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression
Rui Wang et al.
PLOS ONE (2008)
Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin
Andrew M. Intlekofer et al.
SCIENCE (2008)
A Cross-Talk Between Stromal Cell-Derived Factor-1 and Transforming Growth Factor-beta Controls the Quiescence/Cycling Switch of CD34(+) Progenitors Through FoxO3 and Mammalian Target of Rapamycin
Aurelie Chabanon et al.
STEM CELLS (2008)
Decoding the quantitative nature of TGF-β/Smad signaling
David C. Clarke et al.
TRENDS IN CELL BIOLOGY (2008)
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Yukiko Tone et al.
NATURE IMMUNOLOGY (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in mice
Mark A. Travis et al.
NATURE (2007)
TGF-β1 regulates antigen-specific CD4+ T cell responses in the periphery
Richard T. Robinson et al.
JOURNAL OF IMMUNOLOGY (2007)
A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-β
Ramesh K. Selvaraj et al.
JOURNAL OF IMMUNOLOGY (2007)
Negative regulation of TGF-β receptor/Smad signal transduction
Susumu Itoh et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice
Zhiwei Yang et al.
JOURNAL OF CELL BIOLOGY (2007)
Tumor evasion of the immune system by converting CD4+ CD25- T cells into CD4+ CD25+ T regulatory cells:: Role of tumor-derived TGF-β
Victoria C. Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance
Lequn Li et al.
NATURE IMMUNOLOGY (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms
Ming O. Li et al.
IMMUNITY (2006)
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor
Julien C. Marie et al.
IMMUNITY (2006)
Pro- and antiinflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells
Jianhua Yu et al.
IMMUNITY (2006)
Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent
B Valzasina et al.
CANCER RESEARCH (2006)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
TGF-β1 uses distinct mechanisms to inhibit IFN-γ expression in CD4+ T cells at priming and at recall:: Differential involvement of Stat4 and T-bet
JT Lin et al.
JOURNAL OF IMMUNOLOGY (2005)
TGF-β1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells
M Ahmadzadeh et al.
JOURNAL OF IMMUNOLOGY (2005)
Adoptive transfer of tumor-reactive transforming growth factor-β-insensitive CD8+ T cells:: Eradication of autologous mouse prostate cancer
Q Zhang et al.
CANCER RESEARCH (2005)
Distinct effects of TGF-β1 on CD4+ and CD8+ T cell survival, division, and IL-2 production:: A role for T cell intrinsic Smad3
SC McKarns et al.
JOURNAL OF IMMUNOLOGY (2005)
Cutting edge:: TGF-β induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7
MC Fantini et al.
JOURNAL OF IMMUNOLOGY (2004)
Smad3 is essential for TGF-β1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation
SC McKarns et al.
JOURNAL OF IMMUNOLOGY (2004)
TGF-β regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes
YF Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia
NA Bhowmick et al.
SCIENCE (2004)
Transforming growth factor-β pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis
PJ Lucas et al.
CANCER RESEARCH (2004)
p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-β-mediated G1 arrest through modulation of IL-2 responsiveness
LA Wolfraim et al.
JOURNAL OF IMMUNOLOGY (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Antigen-driven effector CD8 T cell function regulated by T-bet
BM Sullivan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma
M Fischer et al.
LEUKEMIA (2003)
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce et al.
SCIENCE (2003)
Transforming growth factor β blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation
CH Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Making sense of latent TGFβ activation
JP Annes et al.
JOURNAL OF CELL SCIENCE (2003)
Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation
L Gorelik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
CM Bollard et al.
BLOOD (2002)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
Regulation of TGF-β response during T cell activation is modulated by IL-10
F Cottrez et al.
JOURNAL OF IMMUNOLOGY (2001)
TGF-β abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells
MA Choudhry et al.
SHOCK (2001)
Altered T-cell receptor+CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-β-treated alloreactive T cells that do not induce graft-versus-host disease
VA Boussiotis et al.
BLOOD (2001)
Cutting edge:: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression
L Gorelik et al.
JOURNAL OF IMMUNOLOGY (2000)
Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor
PJ Lucas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
L Gorelik et al.
IMMUNITY (2000)
Share Paper
